Michael A. Palese, MD | |
---|---|
Education | Cornell University Mount Sinai School of Medicine |
Medical career | |
Profession | Urologist |
Institutions | Mount Sinai Medical Center Mount Sinai Beth Israel |
Sub-specialties | Kidney cancer Kidney stones Minimally Invasive Surgery Robotic Surgery |
Dr. Michael A. Palese, is an American urologist specializing in robotic, laparoscopic and endoscopic surgery, with a special emphasis on robotic surgeries relating to kidney cancer and kidney stone disease. [1] [2]
Palese is the Chairman of the Department of Urology at the Mount Sinai Beth Israel. He is a professor at the Icahn School of Medicine at Mount Sinai in New York City. He is also the Director of Minimally Invasive Surgery for the Mount Sinai Health System and specializes in robotic, laparoscopic and endoscopic surgery.[ citation needed ]
As a board-certified urologist and fellowship-trained surgeon, he specializes in the diagnosis and treatment of kidney, ureter, adrenal, bladder and prostate disease.[ citation needed ]
Palese performed the first robotic radical nephrectomy, robotic partial nephrectomy, robotic donor nephrectomy, robotic nephroureterectomy, robotic adrenalectomy, and robotic ureteral reimplant & reconstruction at the Mount Sinai Medical Center in New York City. He holds several patents for the design of novel surgical devices.[ citation needed ]
He has been included in the Castle Connolly's List of America's “Top Doctors” in 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018 & 2019 and The New York Times publication of “Superdoctors” in 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018 & 2019.[ citation needed ]
Palese graduated from Cornell University in 1993 with a double major degree as well as a minor degree in Human Biology. He received his medical degree (M.D.) from the Mount Sinai School of Medicine in 1997. He completed his general surgery and urology residency at the University of Maryland Medical Center and performed research at the Johns Hopkins Hospital, where he was a research resident. He finished a fellowship in robotic and laparoscopic surgery at Weill Cornell Medical College of Cornell University in 2004. [3]
In 2004, Palese joined the Mount Sinai Medical Center where he established the robotic surgery program for the Department of Urology. He served as the Chief of Urology at the North General Hospital in New York City from 2004 to 2008. [1]
Palese is on the Medical Advisory Board of the National Kidney Foundation of Greater New York and as a consultant for The Journal of Urology. He is on the steering committee for the Initiative on Kidney Cancer (sponsored by the National Kidney Foundation) and serves on the Medical Advisory Board to the New York Giants. [4] He is a member of the American Medical Association (AMA), the American Urological Association (AUA), the New York section of the American Urological Association, and the Society of Laparoscopic Surgeons (SLS). [5] [6]
Professional activities, memberships and distinctions: Palese is the author of book chapters and more than one hundred articles and abstracts. He is on the Medical Advisory Board of the National Kidney Foundation of Greater New York and is a reviewer and consultant for the periodicals of the Journal of Urology, Urology, Urologic Oncology and Journal of Endourology . He is an Editor for the Urologic Oncology (Journal): Seminars and Original Investigations in the section of New Technologies. He is on the steering committee for the Initiative on Kidney Cancer sponsored by the National Kidney Foundation. He also serves on the Medical Advisory Board to the New York Giants. He is a member of multiple organizations including the American Medical Association (AMA), the American Urological Association (AUA), the New York Section of the American Urological Association and the Society of Laparoscopic Surgeons (SLS).[ citation needed ]
Palese lectures and presents his clinical research at national and international medical conferences. As a Visiting Professor he has performed live surgery and given clinical talks in the United States, Austria, Argentina, Canada, Chile, France, Germany, India, Italy, Japan, Poland, Portugal, Spain, and the United Arab Emirates. He teaches and mentors college students, medical students, residents and fellows. He is a course director and faculty member for several educational courses to teach urologists and other physicians. In particular he is a faculty member for the annual Basic Laparoscopy Course sponsored by the American Urological Association in Houston, Texas. He has been a guest faculty member for Laparoscopy Courses in Buenos Aires, Argentina. He has also been the Course Director for several robotic surgery and advanced prostate courses & workshops held at Mount Sinai. He has been featured in the news media on multiple occasions including the New York Times, Wall Street Journal, New York Daily News, CBS, CNN and WPIX TV.[ citation needed ]
Palese is included in the Castle Connolly Medical LTD America's Top Doctors and Top Doctor for Cancer edition, The New York Times published Superdoctors and the New York magazine's annual Top Doctors issue.[ citation needed ]
American Board of Urology
Current clinical trials include:
Urology, also known as genitourinary surgery, is the branch of medicine that focuses on surgical and medical diseases of the urinary system and the reproductive organs. Organs under the domain of urology include the kidneys, adrenal glands, ureters, urinary bladder, urethra, and the male reproductive organs.
A nephrectomy is the surgical removal of a kidney, performed to treat a number of kidney diseases including kidney cancer. It is also done to remove a normal healthy kidney from a living or deceased donor, which is part of a kidney transplant procedure.
Prostatectomy is the surgical removal of all or part of the prostate gland. This operation is done for benign conditions that cause urinary retention, as well as for prostate cancer and for other cancers of the pelvis.
Alexander Gershman is a Russian American surgeon He is considered one of the first surgeons in the world to apply the method of laparoscopic surgery and robotic-assisted surgery to urological surgery and is considered one of the world’s leading experts on minimally invasive surgery. After many years teaching, researching and conducting clinical studies on laparoscopic surgery throughout the world, Gershman is in private practice in Beverly Hills, California. His client list includes numerous Hollywood celebrities and professional athletes.
Dr. Mahendra Bhandari is an Indian surgeon who has made substantial contributions to the specialty of urology, medical training, hospital administration, robotic surgery and medical ethics. For his efforts, he was awarded the Padma Shri by the government of India in 2000. Bhandari is currently Senior Bio-scientist and Director of Robotic Surgery Research & Education at the Vattikuti Urology Institute (VUI) in Detroit, MI. He was the Symposium coordinator of the International Robotic Urology Symposium. He also has been the CEO of the Vattikuti Foundation since 2010.
Mani Menon, born 9 July 1948 in Trichur, India, is an American surgeon whose work has helped to lay the foundation for modern Robotic Cancer Surgery. He is the founding director and the Raj and Padma Vattikuti Distinguished Chair of the Vattikuti Urology Institute at the Henry Ford Hospital in Detroit, MI, where he established the first cancer-oriented robotics program in the world. Menon is widely regarded for his role in the development of robotic surgery techniques for the treatment of patients with prostate, kidney, and bladder cancers, as well as for the development of robotic kidney transplantation.
Ashutosh K. Tewari is the chairman of urology at the Icahn School of Medicine at Mount Sinai Hospital in New York City. He is a board certified American urologist, oncologist, and principal investigator. Before moving to the Icahn School of Medicine in 2013, he was the founding director of both the Center for Prostate Cancer at Weill Cornell Medical College and the LeFrak Center for Robotic Surgery at NewYork–Presbyterian Hospital. Dr. Tewari was the Ronald P. Lynch endowed Chair of Urologic Oncology and the hospital's Director of Robotic Prostatectomy, treating patients with prostate, urinary bladder and other urological cancers. He is the current President of the Society for Urologic Robotic Surgeons (SURS) and the Committee Chair of the Prostate Program. Dr. Tewari is a world leading urological surgeon, and has performed over 10,000 robotically assisted procedures using the da Vinci Surgical System. Academically, he is recognized as a world-renowned expert on urologic oncology with over 250 peer reviewed published papers to his credit; he is on such lists as America's Top Doctors, New York Magazine's Best Doctors, and Who's Who in the World. In 2012, he was given the American Urological Association Gold Cystoscope Award for "outstanding contributions to the field of urologic oncology, most notably the treatment of prostate cancer and the development of novel techniques to improve the outcomes of robotic prostatectomy."
Douglas S. Scherr is an American surgeon and specialist in Urologic Oncology. He is currently the Clinical Director of Urologic Oncology at Weill Cornell Medicine. He also holds an appointment at the Rockefeller University as a Visiting Associate Physician. Scherr was the first physician at Cornell to perform a robotic prostatectomy as well as a robotic cystectomy.
Simon J. Hall is an American researcher who is the Associate Professor and Kyung Hyun Kim, M.D. Chair of Urology and Assistant Professor, Department of Gene and Cell Medicine at The Mount Sinai School of Medicine, as well as the Director of the Barbara and Maurice Deane Prostate Health and Research Center at The Mount Sinai Medical Center, both in New York City.
Roger Sinclair Kirby FRCS(Urol), FEBU is a British retired prostate surgeon and professor of urology. He is prominent as a writer on men's health and prostate disease, the founding editor of the journal Prostate Cancer and Prostatic Diseases and Trends in Urology and Men's Health and a fundraiser for prostate disease charities, best known for his use of the da Vinci surgical robot for laparoscopic prostatectomy in the treatment of prostate cancer. He is a co-founder and president of the charity The Urology Foundation (TUF), vice-president of the charity Prostate Cancer UK, trustee of the King Edward VII's Hospital, and from 2020 to 2024 was president of the Royal Society of Medicine (RSM), London.
Craig G. Rogers, is an American urologist and the Chair of Urology Vattikuti Urology Institute at the Henry Ford Hospital in Detroit, Michigan. Rogers is known for pioneering robotic kidney surgeries using da Vinci Surgical System including single incision robotic surgeries. He was part of a team which pioneered the use of an ultrasound probe in robotic kidney surgery. On February 9, 2009, he performed the first twittered live robotic surgery.
Michael D. Stifelman Michael D. Stifelman, M.D., is Chair of Urology at Hackensack University Medical Center, Director of Robotic Surgery at Hackensack Meridian Health, and Professor and Inaugural Chair of Urology at Hackensack Meridian School of Medicine.
Prokar Dasgupta is an Indian-born British surgeon and academic who is professor of surgery at the surgical academy at King's Health Partners, London, UK. Since 2002, he has been consultant urologist to Guy's Hospital, and in 2009 became the first professor of robotic surgery and urology at King's, and subsequently the chairman of the King's College-Vattikuti Institute of Robotic Surgery.
Narmada Prasad Gupta is an Indian urologist, medical researcher, writer and the chairman of Academics and Research Division Urology at the Medanta, the Medicity, New Delhi. He is credited with over 10,000 urological surgical procedures and the highest number of urology robotics (URobotic) surgeries in India. He is a former head of the department of urology of the All India Institute of Medical Sciences Delhi and a former president of the Urological Society of India. He received the Dr. B. C. Roy Award, the highest Indian award in the medical category, from the Medical Council of India in 2005. The government of India awarded him the fourth highest civilian honour of the Padma Shri, in 2007, for his contributions to Indian medicine.
Vipul R. Patel, FACS is the founder and Medical Director of the AdventHealth’s Global Robotics Institute, founder and Vice President of the Society of Robotic Surgery, and founder and Editor Emeritus of The Journal of Robotic Surgery. He is board certified by the American Urological Association and specializes in robotic surgery for prostate cancer. On April 29, 2024, Dr. Vipul Patel completed his 18,000th robotic-assisted prostatectomy. The large volume of prostatectomies he has performed has enabled him to amass a large amount of statistical evidence regarding the efficacy of robotic techniques which has been used in developing and refining techniques. Patel credits the use of robotic assisted surgery with helping surgeons achieve better surgical outcomes with the "trifecta" of cancer control, continence and sexual function. In the course of his career Patel has led and participated in studies that have resulted in developing improved outcomes for robotic surgery and urologic treatment.
John Ewart Alfred Wickham was a British urologist and surgeon, who was a pioneer of keyhole surgery and the autonomous transurethral resection of the prostate (TURP) robot, foreseeing the subsequent revolution in robotic surgery.
The Urology Foundation (TUF) is a charity that works across the UK and Ireland with the aim of improving the knowledge and skills of surgeons who operate on diseases of the male and female urinary-tract system and the male reproductive organs and funds research to improve outcomes of all urological conditions and urological cancers.
Benjamin James Challacombe is a British consultant urological surgeon at Guy's & St Thomas' Hospitals, and at King’s College London, who specialises in the treatment of kidney and prostatic disease using robotic surgery. In 2005, he was part of the team that published the results of a randomised controlled trial of human versus telerobotics in the field of urology and renal transplant, one of the first of its kind.
Dipen J. Parekh is Chief Operating Officer at the University of Miami Health System, Chairman of Urology and the Dr. Victor Politano Endowed Chair in Clinical Urology at the Miller School of Medicine at University of Miami in Miami. He also serves as the Director of Robotic surgery at the University of Miami Health System.
Declan G. Murphy, FRACS, FRCS, is a urologist, director of the unit for genitourinary oncology and robotic surgery at the Peter MacCallum Cancer Centre in Melbourne, Australia, professor at the Sir Peter MacCallum Department of Oncology at the University of Melbourne, and associate editor of the British Journal of Urology International. In 2010 he introduced robotic surgery for urology to the public sector health services in Victoria, Australia.